Abstract 501
Case Summary
Radioembolization and external radiotherapy are treatment modalities in HCC. Whether there is a role for sequential use of radioembolization and external radiotherapy is presently unknown. Here we report a patient with unresectable HCC treated with radioembolization followed by external radiotherapy. Clinical Presentation 59-year-old male Pakistani patient with hepatitis C treated in 2009 with clearance of virus, presented in 9.2016 with right upper quadrant pain (ECOG 1). He was found to have bifocal liver lesions in the right lobe (V/VI overall 7cm) fulfilling the radiologic criteria for HCC. The tumor marker AFP was 45306 IU/ml (N 0-5) Child-Pugh score was A6. Radioembolization was administered on the 1.12.2016 which was well tolerated, and AFP level decreased to 9393 IU/ml on 1.3.2017. Follow-up imaging with MRI Liver and PET-CT in 3.2017 showed decrease in size of the right liver lesion; However residual enhancing and FDG-avid uptake in the lesion impressive of residual active disease and new FDG-avid retroperitoneal lymph nodes were described. External beam radiotherapy was administered from 26.3.2017 till 27.4.2017 to the primary liver tumor, involved lymph nodes and to high risk nodal to a total of 55 Gy / 50 Gy in 2.2 Gy/ 2.0 Gy per fraction respectively using Volumetric modulated arc therapy (Rapid Arc) with simultaneous integrated boost, no significant toxicity was observed. On the 28.5.2017 AFP was 5.0 IU/ml and imaging in 6.2017 showed regression of the hepatic lesions and complete response of the involved lymph nodes. The patient continued to have remission with complete response radiologically in hepatic lesions and lymph nodes for more than 14 months till present time and AFP remains < 2 IU/ml on 21.5.2018. Patient maintained good performance (ECOG 0) with Child Pugh A5. Conclusions External beam radiotherapy is effective and well tolerated in a patient with rapidly progressing HCC post-radioembolization. The results described here support further studies on sequential radioembolization-external radiotherapy and related response biomarkers.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
161 - Concurrent nivolumab and radiotherapy in treatment of lung squamous cell carcinoma
Presenter: Dai Wee Lee
Session: Poster display - Cocktail
Resources:
Abstract
399 - Adenocarcinoma lung with sphenoidal metastasis
Presenter: Manoj Behera
Session: Poster display - Cocktail
Resources:
Abstract
617 - Osimertinib in the Treatment of Leptomeningeal Disease in T790M-negative, EGFR-mutated NSCLC: A Case Report
Presenter: Lawrence Kasherman
Session: Poster display - Cocktail
Resources:
Abstract
636 - Hemodynamic instability caused by cardiac metastases of non-small cell lung cancer- case studies
Presenter: Chia-I Shen
Session: Poster display - Cocktail
Resources:
Abstract
1302 - The long term survival of a 78 year old female diagnosed with Malignant Epithelial Mesothelioma with peritoneal disease on Pembrolizumab plus Pemetrexed and Carboplatin: a case report
Presenter: Katherine Ruth Oracion
Session: Poster display - Cocktail
Resources:
Abstract